Cargando…
Effects of Metoprolol on Periprocedural Myocardial Infarction After Percutaneous Coronary Intervention (Type 4a MI): An Inverse Probability of Treatment Weighting Analysis
Background: Metoprolol is the most used cardiac selective β-blocker and has been recommended as a mainstay drug in the management of acute myocardial infarction (AMI). However, the evidence supporting this regimen in periprocedural myocardial infarction (PMI) is limited. Methods: This study identifi...
Autores principales: | Li, Duanbin, Li, Ya, Lin, Maoning, Zhang, Wenjuan, Fu, Guosheng, Chen, Zhaoyang, Jin, Chongying, Zhang, Wenbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650586/ https://www.ncbi.nlm.nih.gov/pubmed/34888360 http://dx.doi.org/10.3389/fcvm.2021.746988 |
Ejemplares similares
-
Elevation of Hemoglobin A1c Increases the Atherosclerotic Plaque Vulnerability and the Visit-to-Visit Variability of Lipid Profiles in Patients Who Underwent Elective Percutaneous Coronary Intervention
por: Li, Duanbin, et al.
Publicado: (2022) -
Gensini score values for predicting periprocedural myocardial infarction: An observational study analysis
por: Wang, Yao, et al.
Publicado: (2022) -
Impact of increased inflammation biomarkers on periprocedural myocardial infarction in patients undergoing elective percutaneous coronary intervention: a cohort study
por: Zhao, Liding, et al.
Publicado: (2020) -
Development and Validation of a Risk Score in Chinese Patients With Chronic Heart Failure
por: Lin, Maoning, et al.
Publicado: (2022) -
Prognostic significance of troponin increment after percutaneous coronary intervention: A retrospective study
por: Li, Ya, et al.
Publicado: (2022)